OSURNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORASURE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.68+0.07 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $258.18M
- P/E (TTM)
- –
- Dividend yield
- –
ORASURE TECHNOLOGIES INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products and services | $29.72M | $26.38M | $24.88M | $25.34M | $29.85M | $29.00M | $37.23M | $39.65M | $53.95M | $53.78M | $75.56M | $89.01M | 97.0% | -0.4% |
| HIV | $14.17M | – | – | – | $14.40M | – | – | – | – | – | – | – | 46.2% | -1.6% |
| Sample Management Solutions | $9.88M | – | – | – | $9.86M | – | – | – | – | – | – | – | 32.2% | +0.2% |
| HCV | $3.39M | – | – | – | $4.13M | – | – | – | – | – | – | – | 11.1% | -17.8% |
| Other Product And Services Revenues | $2.29M | – | – | – | $994.00K | – | – | – | – | – | – | – | 7.5% | +129.9% |
| Other | $915.00K | $1.55M | $1.89M | $1.75M | $1.40M | $934.00K | $213.00K | $264.00K | $386.00K | $353.00K | $325.00K | $173.00K | 3.0% | -34.4% |
| COVID-19 | $1.00K | – | – | – | $28.00K | – | – | – | – | – | – | – | 0.0% | -96.4% |
| Risk Assessment Testing | $0 | – | – | – | $446.00K | – | – | – | – | – | – | – | 0.0% | -100.0% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $20.24M | $18.67M | $18.18M | $19.66M | $19.85M | $20.34M | $24.11M | $25.35M | $44.39M | $45.21M | $64.85M | $77.93M | 66.0% | +1.9% |
| Africa | $6.79M | $6.77M | $4.97M | $4.88M | $8.03M | $7.19M | $9.30M | $11.38M | $6.37M | $5.70M | – | – | 22.1% | -15.5% |
| Other regions | $1.88M | $1.03M | $1.28M | $1.25M | $1.25M | $770.00K | $1.51M | $1.06M | $1.42M | $1.62M | $9.22M | $9.27M | 6.1% | +50.5% |
| Europe | $1.74M | $1.45M | $2.33M | $1.30M | $2.12M | $1.64M | $2.53M | $2.13M | $2.16M | $1.60M | $1.81M | $1.99M | 5.7% | -17.7% |
From the segment and revenue-disaggregation notes of Orasure Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.